Diaceutics (DXRX) Competitors

ANGLE (LON:AGL) and Diaceutics (LON:DXRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

Which has preferable earnings and valuation, AGL or DXRX?

Diaceutics has higher revenue and earnings than ANGLE. Diaceutics is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANGLE	£2.02M	18.36	-£18.03M	-£0.07	-164.29
Diaceutics	£26.09M	3.85	-£2.85M	-£0.03	-3,966.67

Does the MarketBeat Community favor AGL or DXRX?

ANGLE received 170 more outperform votes than Diaceutics when rated by MarketBeat users. However, 85.71% of users gave Diaceutics an outperform vote while only 62.33% of users gave ANGLE an outperform vote.

Company	Underperform	Outperform
ANGLE	Outperform Votes 182 62.33%	Underperform Votes 110 37.67%
Diaceutics	Outperform Votes 12 85.71%	Underperform Votes 2 14.29%

Which has more risk and volatility, AGL or DXRX?

ANGLE has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500. Comparatively, Diaceutics has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.

Do analysts recommend AGL or DXRX?

ANGLE presently has a consensus price target of GBX 70, suggesting a potential upside of 508.70%. Diaceutics has a consensus price target of GBX 160, suggesting a potential upside of 34.45%. Given ANGLE's higher possible upside, equities research analysts clearly believe ANGLE is more favorable than Diaceutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ANGLE	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Diaceutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is AGL or DXRX more profitable?

ANGLE has a net margin of 0.00% compared to Diaceutics' net margin of -10.90%. Diaceutics' return on equity of -7.13% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANGLE	N/A	-63.75%	-29.89%
Diaceutics	-10.90%	-7.13%	-6.06%

Does the media prefer AGL or DXRX?

In the previous week, ANGLE had 1 more articles in the media than Diaceutics. MarketBeat recorded 1 mentions for ANGLE and 0 mentions for Diaceutics. Diaceutics' average media sentiment score of 0.00 beat ANGLE's score of -1.32 indicating that Diaceutics is being referred to more favorably in the news media.

Company	Overall Sentiment
ANGLE	Negative
Diaceutics	Neutral

Do institutionals & insiders have more ownership in AGL or DXRX?

18.8% of ANGLE shares are held by institutional investors. Comparatively, 52.4% of Diaceutics shares are held by institutional investors. 16.2% of ANGLE shares are held by insiders. Comparatively, 34.3% of Diaceutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Diaceutics beats ANGLE on 10 of the 16 factors compared between the two stocks.